Abstract
Lung cancer is the leading cause of cancer related death. In the advanced stage of the disease most patients present pleural effusion, which increases morbidity. Pulmonary adenocarcinoma is the most frequent subtype, and approximately 25% of cases have mutations in the KRAS gene. However, an effective treatment for these patients is still a subject of research and several drugs are being …